Search Results - "Sahora, K."

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy by Schindl, M., Függer, R., Götzinger, P., Längle, F., Zitt, M., Stättner, S., Kornprat, P., Sahora, K., Hlauschek, D., Gnant, M

“…Background The potential for a fibrin sealant patch to reduce the risk of postoperative pancreatic fistula (POPF) remains uncertain. The aim of this study was…”
Get full text

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review by Eshmuminov, Dilmurodjon, Aminjonov, Botirjon, Palm, Russell F., Malleo, Giuseppe, Schmocker, Ryan K., Abdallah, Raëf, Yoo, Changhoon, Shaib, Walid L., Schneider, Marcel André, Rangelova, Elena, Choi, Yoo Jin, Kim, Hongbeom, Rose, J. Bart, Patel, Sameer, Wilson, Gregory C., Maloney, Sarah, Timmermann, Lea, Sahora, Klaus, Rössler, Fabian, Lopez-Lopez, Víctor, Boyer, Emanuel, Maggino, Laura, Malinka, Thomas, Park, Jeong Youp, Katz, Matthew H. G., Prakash, Laura, Ahmad, Syed A., Helton, Scott, Jang, Jin-Young, Hoffe, Sarah E., Salvia, Roberto, Taieb, Julien, He, Jin, Clavien, Pierre-Alain, Held, Ulrike, Lehmann, Kuno

“…Background Pancreatic cancer often presents as locally advanced (LAPC) or borderline resectable (BRPC). Neoadjuvant systemic therapy is recommended as initial…”
Get full text

The faith of non-surveilled pancreatic cysts: a bicentric retrospective study by Surci, N., Marchegiani, G., Andrianello, S., Pollini, T., Mühlbacher, J., Jomrich, G., Richwien, P., Tamandl, D., Schindl, M., Bassi, C., Salvia, R., Sahora, K.

“…Incidental discovery of pancreatic cystic neoplasms (PCLs) is a common and steadily increasing occurrence. The aim of this study was to investigate a cohort of…”
Get full text

Metachronous hepatic resection for liver only pancreatic metastases by Schwarz, C., Fitschek, F., Primavesi, F., Stättner, S., Margonis, G.A., Weiss, M.A., Stavrou, G.A., Oldhafer, K.J., Kornprat, P., Wundsam, H., Fischer, I., Längle, F., Függer, R., Hauer, A., Klug, R., Kieler, M., Prager, G., Schindl, M., Stremitzer, S., Bodingbauer, M., Sahora, K., Kaczirek, K.

“…The value of liver resection (LR) for metachronous pancreatic ductal adenocarcinoma (PDAC) metastases remains controversial. However, in light of increasing…”
Get full text

Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms by Sahora, K, Crippa, S, Zamboni, G, Ferrone, C, Warshaw, A.L, Lillemoe, K, Mino-Kenudson, M, Falconi, M, Fernandez-del Castillo, C

“…Abstract Background Intraductal papillary mucinous neoplasms (IPMN) have been reported to be associated with concurrent, distinct pancreatic ductal…”
Get full text

917 The prognostic value of body composition and serum markers of inflammation in patients undergoing surgery for pancreatic cancer by Gruber, E.S, Jomrich, G, Tamandl, D, Friedl, J, Schindl, M, Gnant, M, Sahora, K

Get full text

Common variables in European pancreatic cancer registries: the introduction of the EURECCA pancreatic cancer project by de Leede, E.M, Sibinga Mulder, B.G, Bastiaannet, E, Poston, G.J, Sahora, K, Van Eycken, E, Valerianova, Z, Mortensen, M.B, Dralle, H, Primic-Žakelj, M, Borràs, J.M, Gasslander, T, Ryzhov, A, Lemmens, V.E, Mieog, J.S.D, Boelens, P.G, van de Velde, C.J.H., Prof. dr, Bonsing, B.A

“…Abstract Background Quality assurance of cancer care is of utmost importance to detect and avoid under and over treatment. Most cancer data are collected by…”
Get full text

14. The EURECCA Pancreatic Cancer Project: An overview of the first data by Sibinga Mulder, B.G, Bastiaannet, E, Primic-Žakelj, M, Valerianova, Z, Ryzhov, A, Borràs, J.M, Poston, G.J, Sahora, K, Van Eycken, E, Mortensen, M.B, Henning, D, Gasslander, T, Lemmens, V.E, Boelens, P.G, Mieog, J.S.D, Van de Velde, C.J.H, Bonsing, B.A

Get full text

Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: Risk of malignancy and concomitant ductal adenocarcinoma by Sahora, K, Mino-Kenudson, M, Thayer, S.P, Ferrone, C, Wargo, J, Warshaw, A.L, Lillemoe, K, Fernandez-del Castillo, C

“…Expectant management of patients who do not meet criteria for resection is safe, although the high frequency of borderline tumors (35%) in resected patients…”
Get full text

GNAS and KRAS mutations in multifocal intraductal papillary mucinous neoplasms (IPMN) of the pancreas – Pilot study by Sahora, K, Dias-Santagata, D, Morales-Oyarvide, V, Bernardo, L.A, Iafrate, A.J, Pitman, M.B, Fernandez-del Castillo, C, Mino-Kenudson, M

Get full text

The accuracy of the prognostic index for preoperative outcome estimation in patients undergoing surgery for pancreatic ductal adenocarcinoma by Gruber, E.S., Jomrich, G., Sahora, K., Gnant, M., Schindl, M.

Get full text

The Revised R Status Is an Independent Predictor of Postresection Survival in Pancreatic Cancer after Neoadjuvant Treatment by Leonhardt, C., Pils, D., Jomrich, G., Sahora, K., Warshaw, A.L., Ferrone, C.R., Schindl, M., Lillemoe, K.D., Strobel, O., Fernández-del Castillo, C., Hank, T.

Get full text

Smoking impairs the effect of neoadjuvant FOLFIRINOX on Postresection survival in pancreatic cancer by Leonhardt, C.-S., Pils, D., Qadan, M., Gustorff, C., Sahora, K., Klaiber, U., Warshaw, A., Prager, G., Ferrone, C., Lillemoe, K., Schindl, M., Strobel, O., Castillo, C. Fernández-del, Hank, T.

Get full text

Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience by Surci, Niccolò, Bassi, Claudio, Salvia, Roberto, Marchegiani, Giovanni, Casetti, Luca, Deiro, Giacomo, Bergmann, Christina, Walenta, Klaus, Tamandl, Dietmar, Schindl, Martin, Sahora, Klaus, Mühlbacher, Jakob

“…The impact of surgery on nutritional status, pancreatic function, and symptoms of patients affected by chronic pancreatitis (CP) has not been unequivocally…”
Get more information

A multicentre, prospective, randomized trial evaluating the effect of matrix-bound sealant on pancreatic fistula after partial pancreaticoduodenectomy by Schindl, M., Fuegger, R., Laengle, F., Goetzinger, P., Zitt, M., Staettner, S., Kornprat, P., Sahora, K., Gnant, M.

Get full text

A multicentre, prospective, randomized trial evaluating the effect of matrix-bound sealant on pancreatic fistula after partial pancreaticoduodenectomy by Schindl, M., Fuegger, R., Laengle, F., Goetzinger, P., Zitt, M., Staettner, S., Kornprat, P., Sahora, K., Gnant, M.

Get full text

Impact of an individual pre-habilitation program on body composition, physical fitness and perioperative outcome in patients with pancreatic ductal adenocarcinoma undergoing neoadjuvant treatment by Gruber, E.S., Hasenoehrl, T., Sahora, K., Tamandl, D., Jomrich, G., Prager, G., Schmid, R., Wagner, E., Karin, M., Crevenna, R., Schindl, M.

Get full text

4th Austrian pancreas day: a summary of the surgical management of exocrine pancreatic neoplasms by Sahora, K., Schindl, M., Gnant, M.

“…Summary Background In the twenty-first century management of pancreatic diseases remains a challenge for surgeons, gastroenterologists, anesthesiologists,…”
Get full text

Quality of life in patients with pancreatic cancer during neoadjuvant chemotherapy using gemcitabine and bevazizumab: A pilot study by Fitzal, F., Schindl, M., Wrba, F., Koelblinger, K., Goetzinger, P., Kornek, G., Sahora, K., Gnant, M., Kuehrer, I.

“…Abstract only 330 Background: Neoadjuvant chemotherapy (nCT) for pancreatic cancer is increasing due to the fact that 75% of patients diagnosed with pancreatic…”
Get full text

GNASandKRASmutations in multifocal intraductal papillary mucinous neoplasms (IPMN) of the pancreas - Pilot study by Sahora, K, Dias-Santagata, D, Morales-Oyarvide, V, Bernardo, LA, Iafrate, AJ, Pitman, MB, Fernandez-del Castillo, C, Mino-Kenudson, M

“…Background: IPMN are increasingly diagnosed cystic precursor lesions of pancreatic ductal adenocarcinoma (PDAC) and consist of 4 epithelial subtypes…”
Get full text